## **Core Concept**
Hemophilia is a genetic disorder characterized by the deficiency of **clotting factors**, specifically **Factor VIII** (Hemophilia A) or **Factor IX** (Hemophilia B). This deficiency leads to impaired blood coagulation. Clinically, it manifests as an increased tendency to bleed.

## **Why the Correct Answer is Right**
The correct answer, **PTT (Partial Thromboplastin Time)**, is related to the intrinsic and common pathways of blood coagulation. Hemophilia A and B affect the intrinsic pathway by lacking Factors VIII and IX, respectively. The PTT test evaluates the efficiency of these pathways. An increase in PTT indicates a problem in the intrinsic pathway, which is consistent with the coagulation defect seen in hemophilia.

## **Why Each Wrong Option is Incorrect**
- **Option A: PT (Prothrombin Time)**. This test evaluates the extrinsic and common pathways of coagulation. Since hemophilia affects the intrinsic pathway, PT remains normal.
- **Option C: Platelet count**. This test measures the number of platelets in the blood. Hemophilia is related to a deficiency in clotting factors, not platelet count.
- **Option D: Bleeding time**. This test assesses the body's ability to form a platelet plug and is more related to platelet function or vascular integrity than to coagulation factors.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that hemophilia A and B are diagnosed and differentiated based on their specific clotting factor deficiencies and the results of coagulation studies, particularly **PTT**. A significant rise in PTT with normal PT and platelet count is highly suggestive of hemophilia.

## **Correct Answer:** .